1. The FDA has granted Apple's application for its Apple Watch to be used as a Medical Device Development Tool (MDDT) for atrial fibrillation (AFib) history. This means the Apple Watch can now be used by researchers and medical professionals to help develop new treatments and technologies for managing AFib, a common heart rhythm disorder.

2. The MDDT qualification allows the Apple Watch's AFib history feature to be used as a valid and reliable tool in clinical trials and other medical research. This feature can track and record a user's history of AFib episodes, providing valuable data to researchers and clinicians working on improving AFib management and care.

3. The FDA's decision represents an important milestone for the integration of consumer-focused wearable devices, like the Apple Watch, into the medical and healthcare landscape. It highlights the growing role of such devices in enabling more continuous and personalized health monitoring, which can ultimately lead to better patient outcomes and advancements in medical research.